WCM
UTHR icon

Winton Capital Management’s United Therapeutics UTHR Stock Holding History

Winton Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$51.9M Buy
552,024
+146,989
+36% +$15M 0.36% 92
2013
Q4 		$45.8M Buy
405,035
+272,859
+206% +$24.6M 0.41% 67
2013
Q3 		$10.4M Buy
132,176
+123,829
+1,484% +$9.05M 0.13% 267
2013
Q2 		$549K Buy
+8,347
New +$538K 0.01% 594

Other funds holding UTHR

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

Winton Capital Management's UTHR Position: Q1 2014 in Review

Winton Capital Management increased its United Therapeutics (UTHR) stake by 36% in Q1 2014, buying an estimated $15M and bringing the position to 552,024 shares worth $51.9M. The position accounts for 0.36% of the portfolio, ranked #92.

Winton Capital Management first reported a position in UTHR in Q2 2013 and has held it in 4 quarters since. 309 funds tracked by Wall St. Rank hold UTHR as of Q1 2014.

  • Winton Capital Management held 552,024 shares of United Therapeutics worth $51.9M as of Q1 2014.
  • Winton Capital Management bought 146,989 United Therapeutics shares in Q1 2014, an estimated $15M.
  • United Therapeutics made up 0.36% of Winton Capital Management's portfolio in Q1 2014, its #92 holding.
  • Winton Capital Management first reported a position in United Therapeutics in Q2 2013 and has held it in 4 quarters since.
  • 309 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.